Northern Trust’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.02M Buy
1,162,092
+19,164
+2% +$66.3K ﹤0.01% 2581
2025
Q1
$2.99M Sell
1,142,928
-27,051
-2% -$70.9K ﹤0.01% 2697
2024
Q4
$4.82M Buy
1,169,979
+231,713
+25% +$955K ﹤0.01% 2525
2024
Q3
$6.64M Buy
938,266
+123,854
+15% +$877K ﹤0.01% 2314
2024
Q2
$5.31M Sell
814,412
-13,995
-2% -$91.2K ﹤0.01% 2361
2024
Q1
$6.88M Buy
828,407
+4,057
+0.5% +$33.7K ﹤0.01% 2282
2023
Q4
$9.08M Buy
824,350
+22,992
+3% +$253K ﹤0.01% 2138
2023
Q3
$6.74M Buy
801,358
+7,130
+0.9% +$60K ﹤0.01% 2257
2023
Q2
$9.98M Sell
794,228
-78,194
-9% -$982K ﹤0.01% 2065
2023
Q1
$14.4M Sell
872,422
-9,873
-1% -$163K ﹤0.01% 1774
2022
Q4
$13.2M Buy
882,295
+64,460
+8% +$963K ﹤0.01% 1821
2022
Q3
$18.3M Buy
817,835
+18,886
+2% +$422K ﹤0.01% 1545
2022
Q2
$13.4M Buy
798,949
+148,598
+23% +$2.49M ﹤0.01% 1806
2022
Q1
$19.5M Sell
650,351
-34,039
-5% -$1.02M ﹤0.01% 1699
2021
Q4
$21M Buy
684,390
+108,462
+19% +$3.33M ﹤0.01% 1733
2021
Q3
$18.2M Buy
575,928
+53,822
+10% +$1.7M ﹤0.01% 1868
2021
Q2
$19.1M Buy
522,106
+77,973
+18% +$2.85M ﹤0.01% 1917
2021
Q1
$15.4M Buy
444,133
+88,240
+25% +$3.05M ﹤0.01% 2011
2020
Q4
$14.8M Sell
355,893
-2,165
-0.6% -$90K ﹤0.01% 2004
2020
Q3
$15.2M Buy
+358,058
New +$15.2M ﹤0.01% 1825